Literature DB >> 14559068

Regulation of fatty acid and cholesterol synthesis: co-operation or competition?

Geoffrey F Gibbons1.   

Abstract

Fatty acids and sterols originally evolved symbiotically as structural components of cell membranes. In some respects, control of their biosynthetic pathways reflects their mutual interdependence in defining changes in the physicochemical properties of the membranes in response to the changing internal and external cellular environments. In some tissues of higher animals, however, cholesterol and fatty acids have multifunctional roles. In particular, the liver synthesizes these lipids for export as multimolecular complexes in the form of micellar bile components and lipoproteins. Intrahepatic fatty acid and cholesterol synthesis is dependent upon the balance between hepatic output of these complexes and dietary input of fat and cholesterol. Thus physiological control of these synthetic processes is often co-ordinated at both the transcriptional and post-translational levels. On the other hand, changes in flux through major metabolic pathways, particularly during physiological transitions and as a result of genetic manipulation, affects substrate availability for these pathways. Under these circumstances, regulation reflects a compensatory response to ensure that flux through the lipid pathways remains unchanged. These regulatory changes can best be interpreted in terms of a Metabolic Control Analysis approach. In summary, flux through the fatty acid and cholesterol pathways reflects (a) cellular demand for these lipids, (b) a variable availability of substrates, (c) a combination of (a) and (b).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559068     DOI: 10.1016/s0163-7827(03)00034-1

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  13 in total

1.  Inflammatory demyelination could be attributed to nitric oxide inhibition of cytosolic CoA with failed lipogenesis.

Authors:  William E W Roediger; Geoffrey F Gibbons
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 4.849

2.  FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Authors:  Samuel X Lee; Markus Heine; Christian Schlein; Rajasekhar Ramakrishnan; Jing Liu; Gabriella Belnavis; Ido Haimi; Alexander W Fischer; Henry N Ginsberg; Joerg Heeren; Franz Rinninger; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

3.  Integrating expression profiling and whole-genome association for dissection of fat traits in a porcine model.

Authors:  S Ponsuksili; E Murani; B Brand; M Schwerin; K Wimmers
Journal:  J Lipid Res       Date:  2011-02-02       Impact factor: 5.922

4.  Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis.

Authors:  Adam M Lopez; Jen-Chieh Chuang; Kenneth S Posey; Stephen D Turley
Journal:  Brain Res       Date:  2016-10-24       Impact factor: 3.252

5.  Protective Effects of Emodin on Oxidized Fish Oil-Induced Metabolic Disorder and Oxidative Stress through Notch-Nrf2 Crosstalk in the Liver of Teleost Megalobrama amblycephala.

Authors:  Changyou Song; Bo Liu; Hongxia Li; Yongkai Tang; Xianping Ge; Bo Liu; Pao Xu
Journal:  Antioxidants (Basel)       Date:  2022-06-15

6.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Authors:  Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

7.  Knockdown of FABP5 mRNA decreases cellular cholesterol levels and results in decreased apoB100 secretion and triglyceride accumulation in ARPE-19 cells.

Authors:  Tinghuai Wu; Jane Tian; Roy G Cutler; Richard S Telljohann; David A Bernlohr; Mark P Mattson; James T Handa
Journal:  Lab Invest       Date:  2009-05-11       Impact factor: 5.662

8.  Rice protein improves adiposity, body weight and reduces lipids level in rats through modification of triglyceride metabolism.

Authors:  Lin Yang; Jia-Hou Chen; Jie Lv; Qiong Wu; Tong Xu; Hua Zhang; Qiao-Hong Liu; Hong-Kun Yang
Journal:  Lipids Health Dis       Date:  2012-02-13       Impact factor: 3.876

9.  Genomic analysis of metabolic pathway gene expression in mice.

Authors:  Anatole Ghazalpour; Sudheer Doss; Sonal S Sheth; Leslie A Ingram-Drake; Eric E Schadt; Aldons J Lusis; Thomas A Drake
Journal:  Genome Biol       Date:  2005-07-01       Impact factor: 13.583

10.  Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers.

Authors:  Georgios Pampalakis; Angeliki-Louiza Politi; Anastasios Papanastasiou; Georgia Sotiropoulou
Journal:  Genes Cancer       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.